Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Curanex Pharmaceuticals Inc (CURX) had Pre-Tax Income of $-3.29M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-3.29M |
|
-- |
|
-- |
|
$3.33M |
|
$-3.33M |
|
$0.03M |
|
|
Pre-Tax Income |
$-3.29M |
$-3.29M |
|
$-3.29M |
|
$-3.29M |
|
$-3.29M |
|
$-3.29M |
|
$-3.33M |
|
$-3.29M |
|
28.36M |
|
28.36M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$4.79M |
|
-- |
|
$0.28M |
|
$5.07M |
|
$0.10M |
|
-- |
|
$0.18M |
|
$0.29M |
|
$4.79M |
|
$4.79M |
|
$4.79M |
|
28.36M |
|
| Cash Flow Statement Financials | |
$-2.03M |
|
-- |
|
-- |
|
$4.97M |
|
$2.94M |
|
$-2.03M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
45.95 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.03M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-68.74% |
|
-68.74% |
|
-64.86% |
|
-68.74% |
|
$0.17 |
|
$-0.07 |
|
$-0.07 |
|